Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of Pyrazinamide

Clinical trial NCT02120638 · UNKNOWN

Trial details

NCT number: NCT02120638
Sponsor: Huashan Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Multidrug Resistant Tuberculosis

Start date: 2014-04-01
Primary completion: 2016-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.